61 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 61 separate news trends connected to Clinical Trials, spanning June 19, 2026 through October 14, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 462 article observations and 441 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
GLP-1 drugs, used to treat obesity, are being reevaluated for their potential to treat addiction and depression.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Cancer drug's target mechanism may be different than scientists believed.
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Roche's Sefaxersen hits target in late-stage study for autoimmune disease
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
U. grad with stage 4 cancer heads to Washington to push for clinical trial access
Alzheimer's treatment advances rapidly, raising hopes for patients.
AstraZeneca's COPD drug scores two late-stage trial wins, boosting hopes for a blockbuster treatment.
Novo’s child obesity win sparks hope, but simultaneous heart‑drug trial cuts cloud its broader pipeline.
Novo Nordisk’s sudden halt of two heart‑failure trials slashes hopes for an IL‑6 drug and rattles investors.
Novartis' experimental heart drug Pelacarsen has failed a pivotal study, disappointing investors and cardiologists.
7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Ultragenyx's stock has dropped 40% after a failed trial for its Angelman syndrome drug.
Newly approved pancreatic cancer drug may extend survival for lung cancer patients.
Teva's experimental antibody TEV-408 hits a key phase IIa endpoint in celiac disease studies.
Novartis’s Rhapsido clears two Phase III hurdles, sending its stock soaring.
Recent clinical trials provide mixed messages regarding direct oral anticoagulant therapy following transcatheter aortic valve implantation.
Novartis and Bristol Myers have halted autoimmune CAR-T trials after three patient deaths.
Novartis and Bristol Myers have paused CAR-T trials after patient deaths, raising safety concerns in the biopharma industry.
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
Clinical trial data from ESC 2026 reveals oral anticoagulants reduce stroke risk in intermediate-risk atrial fibrillation patients.
AstraZeneca and Ionis' failed heart disease trial raises questions about the future of RNA drugs
A cancer therapy has shown promise in treating severe rheumatoid arthritis, offering new hope to patients.
A drug used to treat arthritis is showing promise in treating alopecia areata, a condition that causes hair loss.
Roche’s $2.5 billion pact for Hanmi’s muscle‑sparing obesity drug ignites expectations for a new weight‑loss breakthrough
GLP-1 medications, known for weight loss, are now being studied for their potential to treat addictions.
Moderna's cancer vaccine trials could transform treatment, but the math is still out.
Patients eager to join clinical trials face numerous barriers, from financial to logistical.
A cancer vaccine breakthrough is stirring debate over profits and public health, as Moderna and Merck's stock prices surge.
A national trial is exploring whether GLP-1s, known for weight loss, can also help with alcohol use disorder.
A drug designed to mimic exercise has passed its first human test, sparking interest in the medical community.
A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.
EyePoint Pharmaceuticals' stock plummets after a clinical trial setback, leaving investors reeling and analysts divided.
AstraZeneca has abruptly terminated its Phase 3 trial for the lung cancer drug volrustomig, halting development after an internal review.
A single human trial of fecal microbiota transplantation has shown promise in treating peanut allergies.
A new study suggests that stopping statins in low-risk seniors may not increase mortality, but experts debate the findings.
Research indicates AI integration could deliver 82 times the return on investment in oncology clinical trials while reshaping the drug development market.
Alameda-based biotech Infinimmune has secured $75 million in Series A funding to advance its antibody pipeline for atopic dermatitis and inflammatory diseases.
A single blood test could revolutionize cancer detection by identifying multiple cancers earlier.
Silence Therapeutics' new data on a rare blood cancer drug could disrupt Takeda's market position.
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.
Kalshi is defending its plan to allow betting on the lives of cancer patients.
A randomized controlled trial published in Nature indicates that the synthetic cannabinoid Dronabinol effectively reduces trauma-related nightmares in PTSD patients.
A major randomized clinical trial indicates that psilocybin, the active compound in magic mushrooms, provides relief for treatment-resistant depression.
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Human clinical trials have begun for the world's first vaccine targeting the Bundibugyo ebolavirus outbreak.
Eli Lilly's retatrutide shows promising results in weight loss trials, driving stock gains and regulatory anticipation
A first-in-human trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
UCSF has begun screening patients for a novel trial testing whether a combination of two drugs is more effective against Alzheimer's than a single treatment.
A new oral GLP-1 weight-loss pill is showing results that outperform oral Ozempic in major clinical trials.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
New clinical trials and expanded medical facilities offer hope for a viral Ebola strain in the Democratic Republic of Congo that lacks a specific treatment.
A Chinese stem cell transplant trial shows promise for Type 1 diabetes patients.
An experimental drug for pancreatic cancer is generating hope among medical professionals and patients.
The US is providing experimental Ebola treatments for an outbreak in Congo, accelerating clinical trials.
The FDA is launching a pilot program to accelerate early-stage clinical trials to enhance U.S. competitiveness in drug research.